We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+13.6%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$11.5B
AUM Growth
+$373M
Cap. Flow
-$871M
Cap. Flow %
-7.58%
Top 10 Hldgs %
26.56%
Holding
327
New
47
Increased
82
Reduced
128
Closed
45

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$60.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$60.2M
3
ZBH icon
Zimmer Biomet
ZBH
+$58.6M
4
HCA icon
HCA Healthcare
HCA
+$51.7M
5
USFD icon
US Foods
USFD
+$48.9M

Top Sells

Rank Stock Value
1
EXPE icon
Expedia Group
EXPE
+$67.5M
2
NOW icon
ServiceNow
NOW
+$64.3M
3
EW icon
Edwards Lifesciences
EW
+$57.8M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$48.5M
5
IQV icon
IQVIA
IQV
+$47M

Sector Composition

Rank Sector Weight
1 Technology 30.26%
2 Financials 22.36%
3 Healthcare 17.74%
4 Communication Services 10.2%
5 Consumer Discretionary 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
251
Abbott
ABT
$190B
-559,278
Closed -$46.8M
APTV icon
252
Aptiv
APTV
$12.4B
-116,711
Closed -$10.2M
AUPH icon
253
Aurinia Pharmaceuticals
AUPH
$1.93B
-3,312,723
Closed -$17.7M
CME icon
254
CME Group
CME
$95.3B
-150,000
Closed -$31.7M
CPA icon
255
Copa Holdings
CPA
$5.64B
-136,491
Closed -$13.5M
DXCM icon
256
DexCom
DXCM
$29.2B
-768,368
Closed -$28.7M
EW icon
257
Edwards Lifesciences
EW
$48.9B
-788,529
Closed -$57.8M
EXPE icon
258
Expedia Group
EXPE
$36.8B
-502,290
Closed -$67.5M
FATE icon
259
Fate Therapeutics
FATE
$272M
-150,000
Closed -$2.33M
FFIV icon
260
F5
FFIV
$22.4B
-36,000
Closed -$5.05M
FICO icon
261
Fair Isaac
FICO
$32.4B
-9,305
Closed -$2.82M
GILD icon
262
Gilead Sciences
GILD
$166B
-285,000
Closed -$18.1M
GS icon
263
Goldman Sachs
GS
$294B
-1,053
Closed -$218K
INTC icon
264
Intel
INTC
$424B
-48,984
Closed -$2.52M
IONS icon
265
Ionis Pharmaceuticals
IONS
$8.97B
-50,000
Closed -$3M
KEX icon
266
Kirby Corp
KEX
$7.13B
-336,716
Closed -$27.7M
LH icon
267
Labcorp
LH
$25.5B
-279,623
Closed -$40.4M
LLY icon
268
Eli Lilly
LLY
$1.09T
-145,416
Closed -$16.3M
MDLZ icon
269
Mondelez International
MDLZ
$83.7B
-82,881
Closed -$4.58M
MPWR icon
270
Monolithic Power Systems
MPWR
$62.4B
-210,493
Closed -$32.8M
OLED icon
271
Universal Display
OLED
$3.74B
-109,457
Closed -$18.4M
PAGS icon
272
PagSeguro Digital
PAGS
$2.67B
-713,458
Closed -$33M
PODD icon
273
Insulet
PODD
$11.7B
-93,610
Closed -$15.4M
P
274
Everpure Inc
P
$23.6B
-1,273,460
Closed -$21.6M
SAGE
275
DELISTED
Sage Therapeutics
SAGE
-22,500
Closed -$3.16M

Similar funds

Polar Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Polar Capital held 327 positions worth $11.5B, up 3.4% from $11.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Polar Capital withdrew a net $871M in Q4 2019, closing 45 positions and reducing 128 holdings. Its most notable exit was Expedia Group, an estimated $67.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Polar Capital opened a new position in Stryker worth $61.3M.

  • Polar Capital's largest Q4 2019 buy was Stryker: 291,829 shares worth $61.3M.
  • Polar Capital added most to HCA Healthcare in Q4 2019, an estimated $51.7M increase.
  • Polar Capital's biggest Q4 2019 reduction was ServiceNow, cutting an estimated $64.3M.
  • Polar Capital fully exited Expedia Group in Q4 2019, selling an estimated $67.5M.
  • Polar Capital's ten largest holdings make up 27% of its $11.5B portfolio in Q4 2019.
  • Polar Capital opened 47 new positions and closed 45 in Q4 2019.
  • Polar Capital's portfolio value rose 3.4% quarter-over-quarter to $11.5B.

Based on Polar Capital's 13F filing for Q4 2019, filed 14 Feb 2020.